MetLife Investment Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$167K	Buy	46,551 +13,071	+39%	+$51.9K	﹤0.01%	2317
2025 Q4	$118K	Sell	33,480 -12,825	-28%	-$43.9K	﹤0.01%	2535
2025 Q3	$151K	Buy	46,305 +446	+1%	+$1.41K	﹤0.01%	2470
2025 Q2	$112K	Buy	45,859 +1	+0%	+$5	﹤0.01%	2480
2025 Q1	$306K	Buy	45,858 +5,371	+13%	+$53.1K	﹤0.01%	1964
2024 Q4	$509K	Buy	40,487 +2,986	+8%	+$44.9K	﹤0.01%	1788
2024 Q3	$693K	Hold	37,501	–	–	﹤0.01%	1601
2024 Q2	$807K	Buy	37,501 +4,498	+14%	+$103K	﹤0.01%	1461
2024 Q1	$889K	Hold	33,003	–	–	0.01%	1364
2023 Q4	$989K	Buy	33,003 +4,097	+14%	+$90.4K	0.01%	1299
2023 Q3	$592K	Hold	28,906	–	–	﹤0.01%	1526
2023 Q2	$574K	Buy	28,906 +720	+3%	+$14.5K	﹤0.01%	1601
2023 Q1	$483K	Hold	28,186	–	–	﹤0.01%	1667
2022 Q4	$552K	Buy	28,186 +5,211	+23%	+$96K	﹤0.01%	1578
2022 Q3	$367K	Hold	22,975	–	–	﹤0.01%	1863
2022 Q2	$316K	Hold	22,975	–	–	﹤0.01%	1986
2022 Q1	$364K	Buy	22,975 +8,301	+57%	+$143K	﹤0.01%	1973
2021 Q4	$320K	Hold	14,674	–	–	﹤0.01%	1771
2021 Q3	$439K	Hold	14,674	–	–	﹤0.01%	1596
2021 Q2	$650K	Hold	14,674	–	–	0.01%	1421
2021 Q1	$651K	Hold	14,674	–	–	0.01%	1377
2020 Q4	$805K	Hold	14,674	–	–	0.01%	1229
2020 Q3	$335K	Hold	14,674	–	–	﹤0.01%	1574
2020 Q2	$307K	Hold	14,674	–	–	﹤0.01%	1641
2020 Q1	$205K	Hold	14,674	–	–	﹤0.01%	1684
2019 Q4	$334K	Hold	14,674	–	–	﹤0.01%	1676
2019 Q3	$171K	Hold	14,674	–	–	﹤0.01%	2030
2019 Q2	$220K	Buy	14,674 +4,192	+40%	+$73.2K	﹤0.01%	1975
2019 Q1	$184K	Hold	10,482	–	–	﹤0.01%	2021
2018 Q4	$155K	Hold	10,482	–	–	﹤0.01%	2053
2018 Q3	$258K	Buy	+10,482	New	+$227K	﹤0.01%	1945

Other funds holding RCKT